{"name":"Imbrium Therapeutics","slug":"imbrium-therapeutics","ticker":"","exchange":"","domain":"imbrium.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilANBVV95cUxNcXlmcWFkSUVZcGs2VG5XeWcwSm1WNk1hUEdSRElCejNidWx1XzloN3R2dVZyOVAyV1dFWDNqdGQ1bzFPektzejdlQmdXWF9kU2VsaHRtX2QyeTI4UV96T212U3E4bVZwWGNXdDNSR0hMOGZDVTh6S2Y5ajJhREd0NmcxZDVvd05zdldSOV9HZHV6ZndrRWRFbllvZmxSRkxNYkcySGRzRjdiXzduNEhMZEw5YlY4SW1tMXdGd2otc1M2NmRkV0RyY2JMMVQwOVcydkUyT3QwYWR0c2ZITUpKVWd0OXVsaDJBX1N0Zkh2bkhJODFwdmRRSVVETmpWeWxObHF0OWJsdF9VbEthRUhoX2dRM0Zxb282N1BEOXFkanRRN1BTTmVBUmk2VkFfYlJuaDJ1QS14clRNQjhHNTRVeUYxTXRCS1lFczliTm5OVnBQU3M3dFpCbmFVZW1mRmRObTdfWE1rZFBLUkh6S2RFRlIwWUx3dklQcnRBRmdDSjZhN3hGWk01d3hScDBDZnRyOWRnUg?oc=5","date":"2025-11-20","type":"pipeline","source":"prnewswire.com","summary":"Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to Rising Disease Prevalence, Significant Advancements in Genetically-targeted Therapies, along with Innovative Treatments suc","headline":"Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to Rising Disease Prevalence, Significant Adva","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQUl9SMkRtZUhadENIUlV3Z3dneExqdGhtMWZEUGZnNGZ5S1BndU5BdS1sa250bDF6NF9CZW5VMDVFZkNiVVIwSnR0MEJHbExpYlloRno2MEhKc0FDa1ZVMGp0M3JZQmpoRE0wSmhUTWNtTUNJU2VJYnk0Wi1iZmg1ZTVscHZzRGkzNkN2QWJtVExrOWc5bGtSWERDbGZFYnVTeHFuaU9fbm9fOTFEUjU4?oc=5","date":"2025-06-16","type":"pipeline","source":"Contract Pharma","summary":"Imbrium Therapeutics Presents Promising Investigational Agents - Contract Pharma","headline":"Imbrium Therapeutics Presents Promising Investigational Agents","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPLXRjN0s3Y21LN0YzdTRzYnhSbHZiUlpXWVFibjdlVGo1N3dQbm9jbTdkanRFNEpxNDZpUkdINDVWYS1rSkJJRUM3RHdheDJMRWdvbzdkN1dDT1VZTmVlVHJFd0h6MFlZSWZESlpySDJmVS1faHg5ZHk1dkpBSF9YZVIxTzliaklyNjFqNjF4ODUtTjB4M0hITGhHVENQdDF4Vm56UlVqTlRQM0JJdzNRUQ?oc=5","date":"2025-03-11","type":"trial","source":"Urology Times","summary":"Study progresses of sunobinop for interstitial cystitis/bladder pain syndrome - Urology Times","headline":"Study progresses of sunobinop for interstitial cystitis/bladder pain syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxQODRSeHZ1WTg0bnVlRGJqRlNEbDQzZGZ6ejQxNGI0amtJR19NQ1dEeFY5Y2x2MkxpU0pMY1VHSlFkNnRpZy02OGcybmNJdW9YcXJJRmcwUnFQMUNhUDNmTWlMbjdoeFdMVTJTVXUtbjUyeERyWHRqT3dJQkx0TklXRjVzUFNQZHU1WFIyNDdpekFXenprZFc3Z3VXM3FhazBVX202Ukk4S01xMTBGem5ZNE9Xc3V0ZHV4MVpDYk4zVWVSTjNfZnVBN0NyWFZNUk13QVF6ckFObUJhajh4QVNsbjJWWGZieVhxQU9LN3VaWFJCcXZMakZUZDU5MjZsQkJmX0FSWWtxNU5JbXdZWTF0Wnc4SlA3SzJweU9LcHBXYXlCTndxTVliSlh0LU9ta3Qtb1ItV2xrZVVta0k2MWc?oc=5","date":"2025-01-30","type":"trial","source":"GlobeNewswire","summary":"Chronic Pain Clinical Trial Pipeline Experiences Momentum: - GlobeNewswire","headline":"Chronic Pain Clinical Trial Pipeline Experiences Momentum:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOZUpwQXkySFF5OVJVQkNJTm5FWklvdW9PUVM3WEFvNTFwYm56QmpDSnBYMVJtVVVZU0ZURWRublJXMHVDOWp1WlhaekVOVW1QYkx5NjZ0M1pyaUJ1Tm5IMFlsZ2p5LTFuV1JIY280UnF0VDFOdkM1SmNTNjdTUTN6SEwtNXNla2FFTWplT2I0ZElGVWFXU2ZmYkRUR3RtYVE?oc=5","date":"2025-01-07","type":"trial","source":"Urology Times","summary":"Sunobinop shows promise in phase 1b trial for overactive bladder - Urology Times","headline":"Sunobinop shows promise in phase 1b trial for overactive bladder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNRDQxTmZ4QU5wX3lIZTdrdHlWVm9tWFFrY2I2aDl6NTRVdkNBaDh0bGlsOEtyS3AxM21ZRlRLU0wxcmhwQnJQeXYwTDJBWjdCcEFsWEdnb0dUX21hT1o3Z3BwOU9pODhpei1Lc0J1ZFFKR0RobTczOXlOcy1xeTFnb2QzblFEamI4T3VMVHNSNXpKcnpP?oc=5","date":"2024-07-09","type":"trial","source":"Urology Times","summary":"Study progresses of oral compound for overactive bladder - Urology Times","headline":"Study progresses of oral compound for overactive bladder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNSm9XNmJtd2pfSTZxRVNWdTJ0eGd2OVFoN2RxZkpHVnRyeGQ5NllFOWQyVlVqS0FkSlh5UUtkbi1ST2xLN1hrME9raGl4MlpYdEZPbEtoMXVBRnlwNi1CekNwVkVWTG5iM1BWaE4yODcwLWt0VnB1NWs4S3YxcXk0UHZGVGVRUXNvQjRuVlF0aFYzWTV0clplR0VRcEgxdDJfRE9NaFYwWTctLUdsRXpoYnN4eTVBYW8zaVhfaHU5ZUhsM3ZTYkpjQm5XOA?oc=5","date":"2022-12-12","type":"trial","source":"Healio","summary":"Positive preliminary results in phase 2 study of oral treatment for insomnia in AUD - Healio","headline":"Positive preliminary results in phase 2 study of oral treatment for insomnia in AUD","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxObUdxQ0JGQ09xVmltSGE2WkxiQjhPNFhiZDZYZUxFdmlBY21JR1ZPVmh3UXpqR0gxb0w1dFdfVFBhYU0wUm1yXzFwQ2ZSZjUteEd6b2k2bDR1am5tRXJhS1lFQlVGdkZEQWNrQ01NeXNHSmZIMEhORElWS3F6TnRITUgyWW1uSWd2UDRMVTBLb2pxTWEtQ3hVeVVrVk9OemRiZXRB?oc=5","date":"2021-08-11","type":"deal","source":"Fierce Biotech","summary":"Purdue subsidiary buys non-opioid pain prospect from PureTech Health - Fierce Biotech","headline":"Purdue subsidiary buys non-opioid pain prospect from PureTech Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxPT01OZFNIM2dVTEZESU9UV2hweEZkdmN5SU1BU1BRRTYzOTNRLVc2cGp2WVh4X1BqZ0dNYWdRSVE3WEVlcFZ2WThPenVOcVJ2dDZWVTVKU1J3elUtRFdDOXYtdGRqMzRtbk43Nm9BYlNSMDh1Qi15Skt0aWVsc1dFUGM0NEF1M0FPcEVxODEtWGJuRVNnMWtSdkhrUmJNeDJ6Q3VtdXVhUVZNb2V2MW9BVWcteVl0Q2pUb0lDd0tJZU84MjRpZlF3RHJUcHR6LVE3blNMa2tGeXhFWU8yUVQtbmJtU25MdF9WaUNsRzZKYlJvU1RyM3NCSkxJMVh1dlBSM1hfUjRUc2lmMDd5cUhrdE1YMFIzOXE0eXc?oc=5","date":"2019-03-11","type":"regulatory","source":"prnewswire.com","summary":"Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia - prnewswire.com","headline":"Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNTEdrbDFIXzV3ekprazg3MEpTZHVTTGdsX0ZTSE04Umpzak13Z1dWZW51S2kxa2RqX2xkX1YxRDg1ZEJZcGFlWHVsTWtwOWI2YTRHNDJWVm1laUpEdnRnNEJ4eDcyZGZ6aTlubmRLUlhYUm9lZDRjbUhhUlBidTV6ajh1MjQ5NWEzUHFRYUxGNktvZVhXQURxaXZtU1ZGOUFlRzg2T0prRjZtbUh1ZHlFeXdtREVoQUdXdEpadHI4c1RDTEU?oc=5","date":"2019-02-26","type":"pipeline","source":"Fierce Biotech","summary":"Purdue Pharma taps TetraGenetics for ion channel-focused pain treatments in $273M discovery pact - Fierce Biotech","headline":"Purdue Pharma taps TetraGenetics for ion channel-focused pain treatments in $273M discovery pact","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}